R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Medical Science Liaison

Biology & BiotechPosted on Nov 9
Full-timeTokyo, JapanNo salary listed

About the Job

Requirements

  • At least 5 years of experience in Medical Affairs or related functions in the pharmaceutical or biotechnology industry.
  • Strong understanding of oncology clinical development, evidence generation, and the treatment landscape.
  • Ability to analyze and synthesize scientific information effectively.
  • Experience engaging healthcare professionals, academic researchers, and medical societies while following compliance rules.
  • Fluency in Japanese and business-level English.
  • Ability to work effectively in a matrixed, cross-functional, and multicultural environment.
  • Willingness to travel up to 70% of the time.

Responsibilities

  • Support implementation and execution of Medical Affairs strategy and tactical plans for assigned products and therapeutic areas in Japan.
  • Establish and maintain trusted scientific relationships with key opinion leaders, investigators, and healthcare professionals across Japan.
  • Provide medical oversight and scientific input to cross-functional teams, ensuring alignment with regulatory and compliance standards.
  • Contribute medical input to promotional and non-promotional materials, internal training, and advisory boards.
  • Plan and execute medical meetings, education, symposia, and congress participation to enhance scientific visibility.
  • Support investigator-initiated trials and local clinical research activities in collaboration with global and regional teams.
  • Monitor the competitive and scientific landscape to inform internal strategy and provide actionable medical insights.
  • Partner with Health Economics and Outcomes Research and market access teams to develop real-world evidence and outcomes research projects.
  • Ensure compliance with Japan data privacy regulations.
  • Collaborate with Clinical Operations and contract research organizations, including site selection, Site Initiation Visits, and investigator engagement.
  • Provide scientific review to ensure medical accuracy in materials developed by cross-functional teams, including non-promotional content and internal scientific training.

Desired Qualifications

  • Experience leading or supporting investigator-initiated or real-world evidence studies.
  • Track record in publication planning, congress presentations, and scientific communications.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs